Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Total Debt / (EBITDA-CAPEX)

Arbutus Biopharma Cp Total Debt / (EBITDA-CAPEX) Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Total Debt / (EBITDA-CAPEX) from 2006 to 2007.
  • Arbutus Biopharma Cp Total Debt / (EBITDA-CAPEX) for the quarter ending September 09, 2007 was $0m
  • Arbutus Biopharma Cp Total Debt / (EBITDA-CAPEX) for the last 12 months ending March 03, 2008 was $0m a 70.19% increase of 0m year over year
  • Arbutus Biopharma Cp Annual Total Debt / (EBITDA-CAPEX) for 2007 was $0m a 36.31% increase of 0m from 2006
  • Arbutus Biopharma Cp Annual Total Debt / (EBITDA-CAPEX) for 2006 was $0m
Other Ratios Metrics:
  • Arbutus Biopharma Cp Total Debt / Capital for the quarter ending December 12, 2017 was $6m a 3.27% increase of 0m year over year
  • Arbutus Biopharma Cp Other Liabilities for the quarter ending December 12, 2018 was $17m a -61.02% decrease of -10m year over year
  • Arbutus Biopharma Cp Total Debt / Equity for the quarter ending December 12, 2017 was $7m a 3.48% increase of 0m year over year
View Chart On Koyfin

Quarterly ABUS Total Debt / (EBITDA-CAPEX) Data

09/2007$0m
03/2007$0m
12/2006$1m

Annual ABUS Total Debt / (EBITDA-CAPEX) Data

2007$0m
2006$0m